PRESS RELEASE

PLEGRIDYTM (PEGINTERFERON BETA-1A) APPROVED IN THE EUROPEAN UNION FOR THE TREATMENT OF MULTIPLE SCLEROSIS

Read More

About Biogen

Biogen Inc (NASDAQ: BIIB) is one of the leading global biotechnology companies in the world. The company's core capabilities include drug discovery, research, development, biomanufacturing and a global commercial infrastructure...
Read more

BI-GBR-0530(1)
Date of Preparation: March 2015.